Page 3 - Peter Guenter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Positive scientific opinion by EMA would create pathway for arpraziquantel in African endemic countries - News - PharmaTimes

MERCK Kommanditgesellschaft auf Aktien (OTCPK:MKGAF) Q2 2022 Results Conference Call August 04, 2022 08:00 AM ET Company Participants Constantin Fest - Head, IR Belen Garijo - Group, CEO...

Merck KGaA (OTCPK:MKGAF) Q1 2022 Earnings Conference Call May 12, 2022 8:00 AM ET Company Participants Constantin Fest - Head of Investor Relations Belén Garijo - CEO of the Group Marcus...

Merck Announces Appointment of Head of China & International for Healthcare Merck, a leading science and technology company, today announced that Hong Chow will join its Healthcare business sector as Head of China & International on October 1. In this role at Merck, Chow will lead China, Japan as well the regions Europe, Latin America, Asia-Pacific and Middle East, Africa and Russia, the franchise of Cardiovascular Metabolism & Endocrinology (CM&E), and the Global Business Innovation team. Chow will report to Peter Guenter, Member of the Executive Board of Merck and CEO Healthcare. She will s...

Merck invests € 250M in new biotech development centre in Switzerland Merck invests € 250M in new biotech development centre in Switzerland 07 July 2021 | News image credit- businesswire German firm Merck has announced the topping-out ceremony for its new Biotech Development Center in Corsier-sur-Vevey, Switzerland.  This investment of € 250 million, which was announced in January 2020, is intended to help secure the capacities for a cost-efficient and agile provision of clinical study medication in the long term, to shorten the development time of novel biological active ing...